Biosenta Inc. reported earnings results for the third quarter and nine months ended June 30, 2023. For the third quarter, the company reported sales was CAD 0.000197 million compared to CAD 0.000633 million a year ago. Net loss was CAD 0.494459 million compared to CAD 0.282416 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.01 a year ago.
For the nine months, sales was CAD 0.000665 million compared to CAD 0.000925 million a year ago. Net loss was CAD 1.07 million compared to CAD 2.98 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.13 a year ago.